Receive CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This newsletter will focus on addressing the underutilization of azilsartan medoxomil (AZL) among cardiologists in Iraq for hypertension management. Although AZL has demonstrated superior efficacy in reducing blood pressure compared to other angiotensin II receptor blockers (ARBs) like valsartan and olmesartan, it remains underused. The issue likely stems from limited awareness of its pharmacological benefits, dosing considerations, and its potential impact on cardiovascular outcomes. This newsletter aims to provide cardiologists with evidence-based information to bridge this knowledge gap, helping them optimize hypertension treatment by incorporating AZL into their clinical practice.
This activity is designed for an audience of Physicians.
Upon completion of the educational activity, participants should be able to:
To obtain a certificate of completion, a score of 80% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at byron@akhcme.com.
|
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. |
|
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Kikaku America International. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported from an independent medical education grant from Hikma Pharmaceutical.
g>
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
| Name | Relationship | Commercial Interest |
|---|---|---|
| Peter Sonnenreich (planner) | N/A | Nothing to disclose |
| Bossem Wolley, PharmD (faculty) | N/A | Nothing to disclose |
| William B. White, MD(faculty) | N/A | Nothing to disclose |
| Oday Jasim Alsalihi. PhD(faculty) | N/A | Nothing to disclose |
| Ghazi Haji, PhD(faculty) | N/A | Nothing to disclose |
| Hilal Al Saffar,MD(faculty) | N/A | Nothing to disclose |
| Nagham Mualla Karim MBChB / MD /CABM /FICMS cardiology (faculty) | Speaker | Astra Zeneca, Sanofi, Borringher, Bayer, Al - Hikma, Acino /Merck |
| Dorothy Caputo, MA, BSN, RN - VP, Healthcare Continuing Education and Operations | N/A | Nothing to disclose |
| Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
| AKH Inc Staff and Planners | N/A | Nothing to disclose |
| Kikaku America International Staff and Planners | N/A | Nothing to disclose |
| All of the relevant financial relationships listed for these individuals have been mitigated. | ||
